COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT
Aw. Thomson et al., COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT, Immunopharmacology and immunotoxicology, 15(4), 1993, pp. 355-369
The immunosuppressive activity and comparative efficacy of rapamycin (
RAPA), FK 506 and cyclosporine A (CsA) were investigated in rats follo
wing immunization with either xenogeneic sheep red blood cells (SRBC)
or allogeneic blood transfusion. RAPA formulated in a polyethylene gly
col vehicle, and at a dose of 1. 5 mg. kg-1 i.p. , was relatively inef
fective when compared with FK 506 (1 mg.kg-1) or CsA (15 mg.kg-1) in s
uppressing antibody production to SRBC. Like FK 506 and CsA however, R
APA proved highly effective in suppressing both the B lymphocytosis an
d the increase in circulating major histocompatibility complex class I
I+ cells observed following immunization. All three immunosuppressants
caused thymic medullary atrophy, with evidence of epithelial cell dam
age and increased macrophage phagocytic activity. Administered i.m. (3
mg.kg-1 in olive oil), RAPA was also highly effective in suppressing
1-degrees alloantibody responses to MHC class I antigens following blo
od transfusion. Unlike FK 506 and CsA however, a short (14-day) course
of RAPA following 1-degrees immunization (transfusion) did no suppres
s 2-degrees alloantibody responses elicited 6 weeks later. Moreover, R
APA did not prevent immunoglobulin isotype-switching as observed with
FK 506 and CsA. This may reflect the distinct mechanisms of action of
RAPA and the latter two agents on T-cell activation/proliferation. Fur
ther comparative and combination studies of RAPA with in particular, C
sA, are required to further explore to potential of RAPA as an immunot
herapeutic agent,